About 23andMe
23andMe is a company based in Sunnyvale (United States) founded in 2006 was acquired by TTAM Research Institute in June 2025.. 23andMe has raised $943.53 million across 21 funding rounds from investors including Google, Fidelity Investments and Illumina. The company has 265 employees as of March 31, 2024. 23andMe has completed 2 acquisitions, including CureTogether and Icebreaker Health. 23andMe offers products and services including Ancestry Service, Health + Ancestry Service, and 23andMe Premium. 23andMe operates in a competitive market with competitors including Ancestry, Color, Veritas Genetics, Genoplan and GEDmatch, among others.
- Headquarter Sunnyvale, United States
- Employees 265 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 23Andme Holding Co.
-
Annual Revenue
$189.9 M-13.54as on Mar 31, 2024
-
Net Profit
$-280.88 M57.87as on Mar 31, 2024
-
EBITDA
$-155.85 M19.44as on Mar 31, 2024
-
Total Equity Funding
$943.53 M (USD)
in 21 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Nov 03, 2023
-
Investors
Google
& 20 more
-
Employee Count
265
as on Mar 31, 2024
-
Investments & Acquisitions
CureTogether
& 1 more
-
Acquired by
TTAM Research Institute
(Jun 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 23andMe
23andMe is a publicly listed company on the OTC with ticker symbol MEHCQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of 23andMe
23andMe offers a comprehensive portfolio of products and services, including Ancestry Service, Health + Ancestry Service, and 23andMe Premium. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides detailed ancestry breakdowns from genetic data.
Offers health insights alongside ancestry reports through genotyping.
Delivers premium reports and features for ongoing genetic health tracking.
Unlock access to complete
Unlock access to complete
Funding Insights of 23andMe
23andMe has successfully raised a total of $943.53M across 21 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Post-IPO — $20.0M
- First Round First Round
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Post-IPO - 23andMe | Valuation |
investors |
|
| Dec, 2020 | Amount | Series F - 23andMe | Valuation |
investors |
|
| Jul, 2018 | Amount | Series F - 23andMe | Valuation | GSK |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 23andMe
23andMe has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include Google, Fidelity Investments and Illumina. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture capital investment firm
|
Founded Year | Domain | Location | |
|
Long/short equity hedge fund and VC fim
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 23andMe
23andMe has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CureTogether and Icebreaker Health. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of remote patient consultation services and online delivery of medical care products
|
2014 | ||||
|
Quantitative data on medical conditions is shared by users online.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - 23andMe
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
23Andme Comparisons
Competitors of 23andMe
23andMe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ancestry, Color, Veritas Genetics, Genoplan and GEDmatch, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of an online genealogy platform offering a host of services
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
|
| domain | founded_year | HQ Location |
Developer of genetic test kits for health analysis
|
|
| domain | founded_year | HQ Location |
DNA-based health risk assessment platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on 23Andme
Frequently Asked Questions about 23andMe
When was 23andMe founded?
23andMe was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is 23andMe located?
23andMe is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is 23andMe a funded company?
23andMe is a funded company, having raised a total of $943.53M across 21 funding rounds to date. The company's 1st funding round was a Series F of $300M, raised on May 22, 2007.
How many employees does 23andMe have?
As of Mar 31, 2024, the latest employee count at 23andMe is 265.
What is the annual revenue of 23andMe?
Annual revenue of 23andMe is $189.9M as on Mar 31, 2024.
What does 23andMe do?
23andMe was founded in 2006 in Sunnyvale, United States, within the biotechnology sector. Genetic testing services are offered through its platform to analyze individual ancestry, genealogy, and inherited traits. User data is collected, categorized, and supplied in searchable formats to researchers and scientists for further study. Operations focus on direct-to-consumer testing and data aggregation, primarily serving the U.S. market.
Who are the top competitors of 23andMe?
23andMe's top competitors include Ancestry, Veritas Genetics and Color.
What products or services does 23andMe offer?
23andMe offers Ancestry Service, Health + Ancestry Service, and 23andMe Premium.
Is 23andMe publicly traded?
Yes, 23andMe is publicly traded on OTC under the ticker symbol MEHCQ.
How many acquisitions has 23andMe made?
23andMe has made 2 acquisitions, including CureTogether, and Icebreaker Health.
Who are 23andMe's investors?
23andMe has 21 investors. Key investors include Google, Fidelity Investments, Illumina, NIH, and HHS.
What is 23andMe's ticker symbol?
The ticker symbol of 23andMe is MEHCQ on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.